Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.
暂无分享,去创建一个
K. Kent | A. Pichard | L. Satler | R. Torguson | R. Waksman | D. Steinberg | Teruo Okabe | W. Suddath | N. Gevorkian | T. P. Pinto Slottow | P. Roy | Zhenyi Xue | Kimberly A Smith | Tina L. Pinto Slottow | R. Waksman
[1] William Wijns,et al. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. , 2007, Circulation.
[2] Patrick Hunziker,et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. , 2006, Journal of the American College of Cardiology.
[3] Seung‐Jung Park,et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. , 2006, The American journal of cardiology.
[4] Hong Wang,et al. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. , 2006, Journal of the American College of Cardiology.
[5] A. Kastrati,et al. Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006, Circulation.
[6] Seung‐Jung Park,et al. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. , 2006, The American journal of cardiology.
[7] K. Seung,et al. Comparison of sirolimus‐eluting stent, paclitaxel‐eluting stent, and bare metal stent in the treatment of long coronary lesions , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] P. Serruys,et al. "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. , 2005, American heart journal.
[9] P. Fitzgerald,et al. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). , 2005, The American journal of cardiology.
[10] J. Valencia,et al. Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. , 2005, American heart journal.
[11] I. Iakovou,et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. , 2005, Journal of the American College of Cardiology.
[12] Marco Valgimigli,et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. , 2005, Journal of the American College of Cardiology.
[13] J. Schofer,et al. Coronary restenosis after implantation of drug-eluting stents. , 2005, Minerva cardioangiologica.
[14] Patrick W Serruys,et al. Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study , 2004, Circulation.
[15] P. Teirstein,et al. Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis , 2004, Circulation.
[16] P. Fitzgerald,et al. 1139-55 Optimal geometry is still important with sirolimus-eluting stents: Incomplete stent expansion as a risk for target lesion revascularization , 2004 .
[17] I. Iakovou,et al. 1044-55 Overdilation of cypher 3.0 mm 6 cells stent: Clinical consequences , 2004 .
[18] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[19] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[20] Gary S. Mintz,et al. Intravascular Ultrasound Guidance Improves Angiographic and Clinical Outcome of Stent Implantation for Long Coronary Artery Stenoses: Final Results of a Randomized Comparison With Angiographic Guidance (TULIP Study) , 2003, Circulation.
[21] D. Baim,et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. , 2002, Journal of the American College of Cardiology.
[22] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[23] S. Marx,et al. Bench to bedside: the development of rapamycin and its application to stent restenosis. , 2001, Circulation.
[24] P. Teirstein,et al. Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study , 2000 .
[25] M. Hadamitzky,et al. Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.
[26] D. Holmes,et al. Coronary artery stents. , 2000, JAMA.
[27] R. Donehower,et al. Drug therapy : paclitaxel (Taxol) , 1995 .